Informations:
Erreur:
ID
35027
Description
A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02441946
Lien
https://clinicaltrials.gov/show/NCT02441946
Mots-clés
Versions (1)
- 10/02/2019 10/02/2019 -
Détendeur de droits
See clinicaltrials.gov
Téléchargé le
10 février 2019
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Breast Cancer NCT02441946
Eligibility Breast Cancer NCT02441946
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT02441946
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Postmenopausal state
Item
have postmenopausal status.
boolean
C0232970 (UMLS CUI [1])
Breast adenocarcinoma
Item
adenocarcinoma of the breast.
boolean
C0858252 (UMLS CUI [1])
Breast Carcinoma Hormone Receptor Positive Diameter | HER2 negative carcinoma of breast Diameter
Item
breast tumor ≥1 centimeter (cm) in diameter, hr+, her2-.
boolean
C0678222 (UMLS CUI [1,1])
C0019929 (UMLS CUI [1,2])
C1514241 (UMLS CUI [1,3])
C1301886 (UMLS CUI [1,4])
C2316304 (UMLS CUI [2,1])
C1301886 (UMLS CUI [2,2])
C0019929 (UMLS CUI [1,2])
C1514241 (UMLS CUI [1,3])
C1301886 (UMLS CUI [1,4])
C2316304 (UMLS CUI [2,1])
C1301886 (UMLS CUI [2,2])
Hormone Therapy Neoadjuvant
Item
neoadjuvant endocrine monotherapy is deemed to be a suitable therapy.
boolean
C0279025 (UMLS CUI [1,1])
C1298676 (UMLS CUI [1,2])
C1298676 (UMLS CUI [1,2])
Breast Carcinoma Primary Core needle biopsy
Item
primary breast cancer that is suitable for baseline core biopsy.
boolean
C0678222 (UMLS CUI [1,1])
C0205225 (UMLS CUI [1,2])
C1318309 (UMLS CUI [1,3])
C0205225 (UMLS CUI [1,2])
C1318309 (UMLS CUI [1,3])
Organ function
Item
have adequate organ function.
boolean
C0678852 (UMLS CUI [1])
Invasive carcinoma of breast Bilateral
Item
bilateral invasive breast cancer.
boolean
C0853879 (UMLS CUI [1,1])
C0238767 (UMLS CUI [1,2])
C0238767 (UMLS CUI [1,2])
Secondary malignant neoplasm of female breast
Item
metastatic breast cancer (local spread to axillary lymph nodes is permitted).
boolean
C0346993 (UMLS CUI [1])
Inflammatory Breast Carcinoma
Item
inflammatory breast cancer.
boolean
C0278601 (UMLS CUI [1])
Systemic therapy Invasive carcinoma of breast Ipsilateral | Systemic therapy Breast Carcinoma Ipsilateral | Therapeutic radiology procedure Invasive carcinoma of breast Ipsilateral | Therapeutic radiology procedure Breast Carcinoma Ipsilateral
Item
prior systemic therapy or radiotherapy for invasive or non-invasive breast cancer in the same breast as currently being treated.
boolean
C1515119 (UMLS CUI [1,1])
C0853879 (UMLS CUI [1,2])
C0441989 (UMLS CUI [1,3])
C1515119 (UMLS CUI [2,1])
C0678222 (UMLS CUI [2,2])
C0441989 (UMLS CUI [2,3])
C1522449 (UMLS CUI [3,1])
C0853879 (UMLS CUI [3,2])
C0441989 (UMLS CUI [3,3])
C1522449 (UMLS CUI [4,1])
C0678222 (UMLS CUI [4,2])
C0441989 (UMLS CUI [4,3])
C0853879 (UMLS CUI [1,2])
C0441989 (UMLS CUI [1,3])
C1515119 (UMLS CUI [2,1])
C0678222 (UMLS CUI [2,2])
C0441989 (UMLS CUI [2,3])
C1522449 (UMLS CUI [3,1])
C0853879 (UMLS CUI [3,2])
C0441989 (UMLS CUI [3,3])
C1522449 (UMLS CUI [4,1])
C0678222 (UMLS CUI [4,2])
C0441989 (UMLS CUI [4,3])
Radiotherapy to chest wall Ipsilateral Malignant Neoplasm
Item
prior radiotherapy to the ipsilateral chest wall for any malignancy.
boolean
C1998066 (UMLS CUI [1,1])
C0441989 (UMLS CUI [1,2])
C0006826 (UMLS CUI [1,3])
C0441989 (UMLS CUI [1,2])
C0006826 (UMLS CUI [1,3])
Antioestrogen therapy
Item
prior anti-estrogen therapy.
boolean
C0854638 (UMLS CUI [1])